Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A well differentiated, low grade neuroendocrine tumor (carcinoid tumor) that arises from the colon or rectum. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent.
Biomarker and diagnostic research for colorectal neuroendocrine tumor G1 has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy, other interventions, and biologic therapy. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.
30 publications have been identified in PubMed for colorectal neuroendocrine tumor G1. Research spans Case Report / Case Series (47%), Review / Meta-Analysis (13%), and Diagnostic / Biomarker (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 14 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:43 AM UTC
Common questions about colorectal neuroendocrine tumor G1
Research summaries | 4 | 13% |
Testing and diagnosis research | 3 | 10% |
Laboratory research | 3 | 10% |
Disease patterns and progression | 3 | 10% |
New treatment approaches | 2 | 7% |
Clinical study results | 1 | 3% |
Yoon H (2026). [PMID: 42190697](https://pubmed.ncbi.nlm.nih.gov/42190697/). *J Korean Med Sci*. [Diagnostic / Biomarker]
Van Compernolle K (2026). [PMID: 41276290](https://pubmed.ncbi.nlm.nih.gov/41276290/). *J Med Genet*. [Case Report / Case Series]
Lin V (2026). [PMID: 41727240](https://pubmed.ncbi.nlm.nih.gov/41727240/). *J Surg Case Rep*. [Case Report / Case Series]
Dörr J (2026). [PMID: 41673138](https://pubmed.ncbi.nlm.nih.gov/41673138/). *Nat Biomed Eng*. [Basic Science / Preclinical]
Vyas M (2026). [PMID: 41717808](https://pubmed.ncbi.nlm.nih.gov/41717808/). *Am J Surg Pathol*. [Epidemiology / Natural History]
Asmar C (2026). [PMID: 41547118](https://pubmed.ncbi.nlm.nih.gov/41547118/). *Cancer Epidemiol*. [Epidemiology / Natural History]
Karam K (2026). [PMID: 42266391](https://pubmed.ncbi.nlm.nih.gov/42266391/). *Eur J Case Rep Intern Med*. [Basic Science / Preclinical]
Sato K (2026). [PMID: 42146831](https://pubmed.ncbi.nlm.nih.gov/42146831/). *Ann Gastroenterol Surg*. [Clinical Trial Publication]
Xu H (2026). [PMID: 42200202](https://pubmed.ncbi.nlm.nih.gov/42200202/). *Front Genet*. [Basic Science / Preclinical]
Anderson C (2026). [PMID: 41556224](https://pubmed.ncbi.nlm.nih.gov/41556224/). *ANZ J Surg*. [Case Report / Case Series]